Lilly advances obesity and inflammation pipeline with new Phase 1 trials, Phase 2 updatesOct 9Weekly roundup, 10 itemsEli Lillyeloralintide
Lilly posts Phase 3 orforglipron results; two more programs report terminated-trial dataSep 4Weekly roundup, 7 itemsEli Lillylasmiditan